相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Genotyping of the polymorphic N-acetyltransferase (NAT2) and loss of heterozygosity in bladder cancer patients
E. Schnakenberg et al.
CLINICAL GENETICS (2010)
NAT2 Fast Acetylator Genotype and MGMT Promoter Methylation May Contribute to Gender Difference in K-RAS Mutation Occurrence in Taiwanese Colorectal Cancer
Chi-Chou Huang et al.
ENVIRONMENTAL AND MOLECULAR MUTAGENESIS (2009)
Colon tumor mutations and epigenetic changes associated with genetic polymorphism: Insight into disease pathways
Martha L. Slattery et al.
MUTATION RESEARCH-FUNDAMENTAL AND MOLECULAR MECHANISMS OF MUTAGENESIS (2009)
Role of GST and NAT2 polymorphisims in thyroid cancer
A. Hernandez et al.
JOURNAL OF ENDOCRINOLOGICAL INVESTIGATION (2008)
N-acetyltransferase 1 in colon and rectal cancer cases from an industrialized area
Hermann C. Roemer et al.
JOURNAL OF TOXICOLOGY AND ENVIRONMENTAL HEALTH-PART A-CURRENT ISSUES (2008)
Expression of N-acetyltransferase in monocyte-derived dendritic cells
Jutta Lichter et al.
JOURNAL OF TOXICOLOGY AND ENVIRONMENTAL HEALTH-PART A-CURRENT ISSUES (2008)
N-acetyltransferase-2 and medical history in bladder cancer cases with a suspected occupational disease (BK 1301) Germany
Wobbeke Weistenhoefer et al.
JOURNAL OF TOXICOLOGY AND ENVIRONMENTAL HEALTH-PART A-CURRENT ISSUES (2008)
Arylamine N-acetyltransferases: Structural and functional implications of polymorphisms
Edith Sim et al.
TOXICOLOGY (2008)
Tissue expression and genomic sequences of rat N-acetyltransferases rNat1, rNat2, rNat3, and functional characterization of a novel rNat3*2 genetic variant
Jason M. Walraven et al.
TOXICOLOGICAL SCIENCES (2007)
Joint effects of the N-acetyltransferase 1 and 2 (NAT1 and NAT2) genes and smoking on bladder carcinogenesis:: A literature-based systematic HuGE review and evidence synthesis
Simon Sanderson et al.
AMERICAN JOURNAL OF EPIDEMIOLOGY (2007)
Contribution of the N-acetyltransferase 2 polymorphism NAT2*6A to age-related hearing impairment
E. Van Eyken et al.
JOURNAL OF MEDICAL GENETICS (2007)
Functional characterization of single-nucleotide polymorphisms and haplotypes of human N-acetyltransferase 2
Yu Zang et al.
CARCINOGENESIS (2007)
2-amino-1-methyl-6-phenylimidazo [4,5-b] pyridine-induced DNA adducts and genotoxicity in Chinese hamster ovary (CHO) cells expressing human CYP1A2 and rapid or slow acetylator N-acetyltransferase 2
Kristin J. Metry et al.
MOLECULAR CARCINOGENESIS (2007)
NAT2 fast acetylator genotype is associated with an increased risk of colorectal cancer in Taiwan
Chi-Chou Huang et al.
DISEASES OF THE COLON & RECTUM (2007)
Characterization of N-acetyltransferase 1 and 2 polymorphisms and haplotype analysis for inflammatory bowel disease and sporadic colorectal carcinoma
Suhal S. Mahid et al.
BMC MEDICAL GENETICS (2007)
Identification of N-acetyltransferase 2 (NAT2) transcription start sites and quantitation of NAT2-specific mRNA in human tissues
Anwar Husain et al.
DRUG METABOLISM AND DISPOSITION (2007)
N-acetyltransferase 2 slow acetylator genotype associated with adverse effects of sulfasalazine in the treatment of inflammatory bowel disease
Min Chen et al.
CANADIAN JOURNAL OF GASTROENTEROLOGY (2007)
Description of a novel polymorphic gene encoding for arylamine N-acetyltransferase in the rhesus macaque (Macaca mulatta), a model animal for endometriosis
Giannoulis Fakis et al.
PHARMACOGENETICS AND GENOMICS (2007)
Concordance between the deduced acetylation status generated by high-speed real-time PCR based NAT2 genotyping of seven single nucleotide polymorphisms and human NAT2 phenotypes determined by a caffeine assay
Hans-Peter Rihs et al.
CLINICA CHIMICA ACTA (2007)
Analysis of associations of NAT2 gene polymorphisms with the risk of lung cancer
M. V. Nikishina et al.
BULLETIN OF EXPERIMENTAL BIOLOGY AND MEDICINE (2007)
Slow acetylator genotype of N-acetyl transferase2 (NAT2) is associated with increased susceptibility to gallbladder cancer - The cancer risk not modulated by gallstone disease
Sachchida Nand Pandey et al.
CANCER BIOLOGY & THERAPY (2007)
Arylamine N-acetyltransferases
Edith Sim et al.
EXPERT OPINION ON DRUG METABOLISM & TOXICOLOGY (2007)
Functional characterization of the A(411T) (L137F) and G(364)A (D122N) genetic polymorphisms in human N-acetyltransferase 2
Yu Zang et al.
PHARMACOGENETICS AND GENOMICS (2007)
Association of genetic polymorphisms of N-acetyltransferase 2 and susceptibility to esophageal cancer in North Indian population
Meenu Jain et al.
CANCER INVESTIGATION (2007)
Polymorphisms in GSTT1, GSTM1, NAT1 and NAT2 genes and bladder cancer risk in men and women
Monica McGrath et al.
BMC CANCER (2006)
Risk of limb deficiency defects associated with NAT1, NAT2, GSTT1, GSTM1, and NOS3 genetic variants, maternal smoking, and vitamin supplement intake
Suzan L. Carmichael et al.
AMERICAN JOURNAL OF MEDICAL GENETICS PART A (2006)
DNA microarray genotyping of N-acetyltransferase 2 polymorphism using carbodiimide as the linker for assessment of isoniazid hepatotoxicity
Yasuo Shimizu et al.
TUBERCULOSIS (2006)
N-acetyltransferase-1 gene polymorphisms and correlation between genotype and its activity in a central Chinese Han population
Xu Zhangwei et al.
CLINICA CHIMICA ACTA (2006)
Genetic variation in N-acetyltransferase 1 (NAT1) and 2 (NAT2) and risk of non-Hodgkin lymphoma
Lindsay M. Morton et al.
PHARMACOGENETICS AND GENOMICS (2006)
Loss of function polymorphisms in NAT1 protect against spina bifida
Liselotte E. Jensen et al.
HUMAN GENETICS (2006)
N-acetyltransferase 2 ( NAT2) gene polymorphisms in colon and lung cancer patients
Juergen Borlak et al.
BMC MEDICAL GENETICS (2006)
N-acetyltransferase 2 (NAT2) gene polymorphisms in Parkinson's disease -: art. no. 30
J Borlak et al.
BMC MEDICAL GENETICS (2006)
N-acetyltransferase 2 genetic polymorphism:: effects of carcinogen and haplotype on urinary bladder cancer risk
DW Hein
ONCOGENE (2006)
SNP selection at the NAT2 locus for an accurate prediction of the acetylation phenotype
A Sabbagh et al.
GENETICS IN MEDICINE (2006)
Effect of NAT1 and NAT2 genetic polymorphisms on colorectal cancer risk associated with exposure to tobacco smoke and meat consumption
C Lilla et al.
CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION (2006)
4,4'-Methylenedianiline-induced hepatotoxicity is modified by N-acetyltransferase 2 (NAT2) acetylator polymorphism in the rat
XY Zhang et al.
JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS (2006)
NAT2 slow acetylation and bladder cancer in workers exposed to benzidine
T Carreon et al.
INTERNATIONAL JOURNAL OF CANCER (2006)
Crohn's disease in Japanese is associated with a SNP-haplotype of N-acetyltransferase 2 gene
Haruhisa Machida et al.
WORLD JOURNAL OF GASTROENTEROLOGY (2005)
NAT2 slow acetylation, GSTM1 null genotype, and risk of bladder cancer:: results from the Spanish Bladder Cancer Study and meta-analyses
M García-Closas et al.
LANCET (2005)
NAT2 slow acetylator genotype as an important modifier of breast cancer risk
P Sillanpää et al.
INTERNATIONAL JOURNAL OF CANCER (2005)
Effects of N-acetyl transferase 1 and 2 polymorphisms on bladder cancer risk in Caucasians
J Gu et al.
MUTATION RESEARCH-GENETIC TOXICOLOGY AND ENVIRONMENTAL MUTAGENESIS (2005)
Interaction effect in bladder cancer between N-acetyltransferase 2 genotype and alcohol drinking
CM Lu et al.
UROLOGIA INTERNATIONALIS (2005)
Arylamine N-acetyltransferases: What we learn from genes and genomes
S Boukouvala et al.
DRUG METABOLISM REVIEWS (2005)
Identification and functional characterization of novel polymorphisms associated with the genes for arylamine N-acetyltransferases in mice
S Boukouvala et al.
PHARMACOGENETICS (2002)
Variation in enzymes of arylamine procarcinogen biotransformation among bladder cancer patients and control subjects
SAJ Vaziri et al.
PHARMACOGENETICS (2001)
Correlation between acetylation phenotype and genotype in Chinese women
B Zhao et al.
EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY (2000)
N-acetyltransferase 2 and bladder cancer:: an overview and consideration of the evidence for gene-environment interaction
J Green et al.
BRITISH JOURNAL OF CANCER (2000)
Polymorphisms of N-acetyltransferase 2, glutathione S-transferase Mu and theta genes as risk factors of bladder cancer in relation to asthma and tuberculosis
WJ Kim et al.
JOURNAL OF UROLOGY (2000)
Identification of amino acids imparting acceptor substrate selectivity to human arylamine acetyltransferases NAT1 and NAT2
GH Goodfellow et al.
BIOCHEMICAL JOURNAL (2000)
Relationship between NAT1 genotype and phenotype in a Japanese population
M Yang et al.
PHARMACOGENETICS (2000)
Gender-specific effects of NAT2 and GSTM1 in bladder cancer
E Schnakenberg et al.
CLINICAL GENETICS (2000)
NAT2 slow acetylation and bladder cancer risk: a metaanalysis of 22 case-control studies conducted in the general population
PM Marcus et al.
PHARMACOGENETICS (2000)
分享论文
